IP Library › Granted Patent US 7,390,823
Granted Patent B2
US 7,390,823 · App. 10/409,504 · Granted Jun 24, 2008

Use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,390,823
App. No.
10/409,504
Granted
Jun 24, 2008
Kind
B2
Abstract

The present invention relates to the use of saredutant and of its pharmaceutically acceptable salts for the preparation of medicinal products that are useful in the treatment or prevention of all mood disorders, adaptation disorders or mixed anxiety-depression disorders.

Claims (1)

1. A method for the treatment of major depressive disorders which comprises administering to a patient in need of such treatment an effective amount of saredutant or a pharmaceutically acceptable salt thereof.